User profiles for "author:Jan Gerstoft"

jan gerstoft

professor clinical virology, University of Copenhagen
Verified email at rh.dk
Cited by 35563

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

D Razavi-Shearer, I Gamkrelidze… - The lancet …, 2018 - thelancet.com
Summary Background The 69th World Health Assembly approved the Global Health Sector
Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis …

[HTML][HTML] Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions

JC Gaardbo, HJ Hartling, J Gerstoft… - Journal of Immunology …, 2012 - hindawi.com
Treatment of HIV-infected patients with highly active antiretroviral therapy (HAART) usually
results in diminished viral replication, increasing CD4+ cell counts, a reversal of most …

Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy

AJ Rodger, V Cambiano, T Bruun, P Vernazza… - Jama, 2016 - jamanetwork.com
Importance A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral
therapy (ART) as a prevention strategy is the absolute risk of HIV transmission through …

[HTML][HTML] Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy …

AJ Rodger, V Cambiano, T Bruun, P Vernazza… - The Lancet, 2019 - thelancet.com
Background The level of evidence for HIV transmission risk through condomless sex in
serodifferent gay couples with the HIV-positive partner taking virally suppressive …

Survival of persons with and without HIV infection in Denmark, 1995–2005

N Lohse, ABE Hansen, G Pedersen… - Annals of internal …, 2007 - acpjournals.org
Background: The expected survival of HIV-infected patients is of major public health interest.
Objective: To estimate survival time and age-specific mortality rates of an HIV-infected …

A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus

TN Kledal, MM Rosenkilde, F Coulin, G Simmons… - Science, 1997 - science.org
Kaposi's sarcoma–associated herpesvirus encodes a chemokine called vMIP-II. This protein
displayed a broader spectrum of receptor activities than any mammalian chemokine as it …

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

H Razavi, I Waked, C Sarrazin, RP Myers… - Journal of viral …, 2014 - Wiley Online Library
The disease burden of hepatitis C virus (HCV) is expected to increase as the infected
population ages. A modelling approach was used to estimate the total number of viremic …

Mortality attributable to smoking among HIV-1–infected individuals: a nationwide, population-based cohort study

M Helleberg, S Afzal, G Kronborg… - Clinical Infectious …, 2013 - academic.oup.com
Background. We assessed mortality attributable to smoking among patients with human
immunodeficiency virus (HIV). Methods. We estimated mortality rates (MRs), mortality rate …

Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT …

HJ Stellbrink, C Orkin, JR Arribas… - Clinical Infectious …, 2010 - academic.oup.com
Background. Abacavir-lamivudine and tenofovir DF-emtricitabine fixed-dose combinations
are commonly used as first-line antiretroviral therapies. However, few studies have …

Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin

P Garred, HO Madsen, U Balslev, BO Hofmann… - The Lancet, 1997 - thelancet.com
Background Low serum concentrations of mannose-binding lectin (MBL) are associated with
increased susceptibility to recurrent infection. Three variant alleles in the MBL gene (B, C …